These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 15107888)

  • 1. Treatment of Machado-Joseph disease with trimethoprim-sulphamethoxazole following successful desensitisation.
    Ablin J; Elgan N
    N Z Med J; 2004 Apr; 117(1191):U819. PubMed ID: 15107888
    [No Abstract]   [Full Text] [Related]  

  • 2. Successful desensitization to trimethoprim-sulfamethoxazole after allogeneic haematopoietic stem cell transplantation: preliminary observations.
    Soffritti S; Ricci G; Prete A; Rondelli R; Menna G; Pession A
    Med Pediatr Oncol; 2003 Apr; 40(4):271-2. PubMed ID: 12555266
    [No Abstract]   [Full Text] [Related]  

  • 3. Successful outpatient graded administration of trimethoprim-sulfamethoxazole in patients without HIV and with a history of sulfonamide adverse drug reaction.
    Pyle RC; Butterfield JH; Volcheck GW; Podjasek JC; Rank MA; Li JT; Harish A; Poe KL; Park MA
    J Allergy Clin Immunol Pract; 2014; 2(1):52-8. PubMed ID: 24565769
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sulfa hypersensitivity in patients with HIV infection: onset, treatment, critical review of the literature.
    Ryan C; Madalon M; Wortham DW; Graziano FM
    WMJ; 1998 May; 97(5):23-7. PubMed ID: 9617304
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Trimethoprim-sulfamethoxazole and biopterin treatment in Machado-Joseph disease.
    Sakai T
    Mov Disord; 1998 May; 13(3):622. PubMed ID: 9613774
    [No Abstract]   [Full Text] [Related]  

  • 6. Evaluation of the effect of sulphametoxazole and trimethoprim in patients with Machado-Joseph disease.
    Correia M; Coutinho P; Silva MC; Guimarães J; Amado J; Matos E
    Rev Neurol; 1995; 23(121):632-4. PubMed ID: 8597984
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TMP-SMX desensitization.
    Posit Aware; 1995; ():7. PubMed ID: 11362574
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Familial tendency in hypersensitivity reactions to co-trimoxazole.
    Mohanasundaram J; Rajaram S; Mohanasundaram S
    J Indian Med Assoc; 1998 Jan; 96(1):21-2. PubMed ID: 9601187
    [No Abstract]   [Full Text] [Related]  

  • 9. [Seven hours for effective and safe desensitization in HIV-positive patients intolerant to cotrimoxazole].
    El Benaye J; Nihal B; Hicham J; Mohamed E
    Pan Afr Med J; 2014; 18():238. PubMed ID: 25426196
    [No Abstract]   [Full Text] [Related]  

  • 10. Study finds NAC fails to prevent Bactrim/Septra hypersensitivity.
    TreatmentUpdate; 1999 Feb; 11(1):4-5. PubMed ID: 11366023
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Value of desensitization for reintroducing trimethoprim-sulfamethoxazole in hypersensitive patients with HIV infection].
    Caumes E
    Ann Med Interne (Paris); 1997; 148(2):172-6. PubMed ID: 9238444
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Allergy to trimethoprim-sulfamethoxazole in normal, atopic and immunodepressed subjects].
    Pioda GB; Del Favero A; Menichetti F; Spinozzi F; Gernini I; Rambotti P
    Clin Ter; 1987 Aug; 122(3):171-5. PubMed ID: 2973909
    [No Abstract]   [Full Text] [Related]  

  • 13. Efficacy and safety of desensitization with sulfamethoxazole and trimethoprim in 48 previously hypersensitive patients infected with human immunodeficiency virus.
    Caumes E; Guermonprez G; Lecomte C; Katlama C; Bricaire F
    Arch Dermatol; 1997 Apr; 133(4):465-9. PubMed ID: 9126010
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Flare-up of patch test of trimethoprim-sulfamethoxazole (co-trimoxazole) during oral desensitization.
    Kardaun SH; de Waard MM; de Monchy JG
    Contact Dermatitis; 2009 Jul; 61(1):50-1. PubMed ID: 19659967
    [No Abstract]   [Full Text] [Related]  

  • 15. Trimethoprim-sulfamethoxazole-associated hepatotoxicity - part of a hypersensitivity syndrome.
    Mainra RR; Card SE
    Can J Clin Pharmacol; 2003; 10(4):175-8. PubMed ID: 14712321
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Newly diagnosed human immunodeficiency virus after sepsis-like reaction of trimethoprim-sulfamethoxazole.
    Moran KA; Ales NC; Hemmer PA
    South Med J; 2001 Mar; 94(3):350-2. PubMed ID: 11284528
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Trimethoprim-sulphamethoxazole desensitization in HIV-infected patients: an open study.
    Bachmeyer C; Salmon D; Guérin C; Barré C; Hazebroucq G; Sicard D; Séréni D
    AIDS; 1995 Mar; 9(3):299-300. PubMed ID: 7755920
    [No Abstract]   [Full Text] [Related]  

  • 18. Fixed drug eruption induced by trimethoprim-sulfamethoxazole: evidence for a link to HLA-A30 B13 Cw6 haplotype.
    Ozkaya-Bayazit E; Akar U
    J Am Acad Dermatol; 2001 Nov; 45(5):712-7. PubMed ID: 11606921
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Desensitization in HIV seropositive patients with cotrimoxazole hypersensitivity. A series of 18 cases].
    Amedeo J; Chichmanian RM; Reboulot B; Vinti H; Rosenthal E; Pesce A; Cassuto JP
    Therapie; 1994; 49(5):463-5. PubMed ID: 7855770
    [No Abstract]   [Full Text] [Related]  

  • 20. Polysensitivity in fixed drug eruption due to a novel drug combination-independent lesions due to piroxicam and cotrimoxazole.
    Ozkaya E
    Eur J Dermatol; 2006; 16(5):591-2. PubMed ID: 17101493
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.